Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.

Objectives Gout is a common disease causing excruciatingly painful and disabling flares. Although currently approved treatments for gout flares are generally effective, their use is restricted in many ...